The present invention is directed to inhibiting amyloidogenic processing of amyloid precursor protein, and/or inhibiting production of amyloid beta peptides. These methods can involve accelerating cis/trans isomerization of amyloid precursor protein at a phosphorylated serine/threonine-proline motif and/or contacting a cell with a compound that mimics the cis conformation of a phosphorylated serine/threonine-proline motif of an amyloid precursor protein. The present invention also relates to treating and/or preventing in a subject a degenerative neurological disease characterized by amyloidogenic processing of amyloid precursor protein and/or overproduction of amyloid beta peptide. This method involves administering an agent that accelerates cis/trans isomerization of amyloid precursor protein at a phosphorylated serine/threonine-proline motif and/or inhibits production of amyloid β peptides. Methods of screening for therapeutic agents effective in treating and/or preventing such diseases, methods of screening for biological molecules involved in the amyloidogenic pathway, and compounds that mimic the cis conformation of a phosphorylated serine/threonine-proline motif of an amyloid precursor protein are also disclosed.
本发明旨在抑制淀粉样前体蛋白的淀粉样加工,并/或抑制淀粉样β肽的产生。这些方法可以涉及加速
磷酸化
丝氨酸/苏
氨酸-脯
氨酸基序的淀粉样前体蛋白的顺反异构化,和/或用类似于淀粉样前体蛋白
磷酸化
丝氨酸/苏
氨酸-脯
氨酸基序的顺式构象的化合物接触细胞。本发明还涉及用于治疗和/或预防患有淀粉样前体蛋白淀粉样加工和/或淀粉样β肽过度产生的退行性神经疾病的方法。该方法涉及给予一种能加速淀粉样前体蛋白
磷酸化
丝氨酸/苏
氨酸-脯
氨酸基序的顺反异构化和/或抑制淀粉样β肽产生的药物。还公开了筛选用于治疗和/或预防此类疾病的治疗剂的方法,筛选参与淀粉样加工途径的
生物分子的方法,以及类似于淀粉样前体蛋白
磷酸化
丝氨酸/苏
氨酸-脯
氨酸基序的顺式构象的化合物。